B Group, Inc. Taysha Gene Therapies, Inc. Transaction History
B Group, Inc.
- $117 Billion
- Q1 2025
A detailed history of B Group, Inc. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, B Group, Inc. holds 1,255,556 shares of TSHA stock, worth $3.38 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
1,255,556
Previous 965,556
30.03%
Holding current value
$3.38 Million
Previous $1.67 Billion
4.48%
% of portfolio
1.5%
Previous 1.02%
Shares
2 transactions
Others Institutions Holding TSHA
# of Institutions
129Shares Held
152MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$53.8 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$50.5 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$45.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$31.6 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$29.2 Million0.31% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $130M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...